Page 104 - 《中国药房》2021年21期
P. 104

[ 7 ]  ZHANG Z,YANG C,ZHANG L L,et al. Pharmacothera-    Med Ther,2016,27(7):57-64.
             pies to tics:a systematic review[J]. Oncotarget,2018,9  [20]  WANG S,WEI Y Z,YANG J H,et al. The efficacy and
             (46):28240-28266.                                   safety of aripiprazole for tic disorders in children and ado-
        [ 8 ]  HOLLIS C,PENNANT M,CUENCA J,et al. Clinical       lescents:a systematic review and meta-analysis[J]. Psychiatry
             effectiveness and patient perspectives of different treat-  Res,2017,254:24-32.
             ment strategies for tics in children and adolescents with  [21]  LIU Y Y,NI H ,WANG C H,et al. Effectiveness and tole-
             Tourette syndrome:a systematic review and qualitative  rability of aripiprazole in children and adolescents with
             analysis[J]. Health Technol Assess,2016,20(4):441-450.  Tourette’s disorder:a meta-analysis[J]. J Child Adolesc
        [ 9 ]  WHITTINGTON C,PENNANT M,KENDALL T,et al.          Psychopharmacol,2016,26(5):436-441.
             Practitioner review:treatments for tourette syndrome in  [22]  ZHENG W,LI X B,XIANG Y Q,et al. Aripiprazole for
             children and young people:a systematic review[J]. J Child  Tourette’s syndrome:a systematic review and meta-analy-
             Psychol Psyc,2016,57(9):988-1004.                   sis[J]. Hum Psychopharmacol,2016,31(1):11-18.
        [10]  OSLAND S T,STEEVES T D L,PRINGSHEIM T. Phar-  [23]  PRINGSHEIM T,MARRAS C. Pimozide for tics in
             macological treatment for attention deficit hyperactivity  Tourette’s syndrome[J]. Cochrane Database Syst Rev,
             disorder(ADHD)in children with comorbid tic disorders  2009(2):CD006996.
             [J]. Cochrane Database Syst Rev,2018(6):CD007990.  [24]  宋好鑫,黄宗瑶,杨春松,等.可乐定治疗儿童抽动障碍的
        [11]  WEISMAN H,QURESHI I A,LECKMAN J F,et al. Sys-      有效性与安全性的Meta分析[J].中国药房,2019,30(1):
             tematic review:pharmacological treatment of tic disor-  125-130.
             ders:efficacy of antipsychotic and alpha-2 adrenergic ago-  [25]  柯钟灵,陈燕惠,念欲霞,等.可乐定治疗儿童抽动障碍疗
             nist agents[J].Neurosci Biobehav Rev,2013,37(6):1162-  效与安全性的系统评价和Meta分析[J].中国循证儿科杂
             1171.                                               志,2016,11(6):426-430.
        [12]  YANG C S,HAO Z L,ZHANG L L,et al. Comparative  [26]  WANG S,WEI Y Z,YANG J,et al. Clonidine adhesive
             efficacy and safety of antipsychotic drugs for tic disor-  patch for the treatment of tic disorders:a systematic re-
             ders:a systematic review and bayesian network meta-analy-  view and meta-analysis[J]. Eur J Paediatr Neurol,2017,21
             sis[J]. Pharmacopsychiatry,2018,52(1):7-15.        (4):614-620.
        [13]  CHENG W T,LIN L,GUO S N. A Meta-analysis of the  [27]  YANG C S,ZHANG L L,ZENG L N,et al. Topiramate
             effectiveness of risperidone versus traditional agents for  for Tourette’s syndrome in children:a meta-analysis[J].
             Tourette’s syndrome[J]. J Cent South Univ,2012,37(4):  Pediatr Neurol,2013,49(5):344-350.
             359-365.                                       [28]  ZHENG W,ZHANG N,YANG J H,et al. Meta-analysis
        [14]  CHANG X C,ZHENG R Y,ZHANG Z X,et al. Systematic    of children with tic disorder treated with topiramate and
             review of the treatment of Tourette syndrome with risperi-  haloperidol[J]. Chin J Child Health Care,2015,23(3):
             done[J]. Chin J Pharmacoepidemiol,2010,19(10):545-  303-309.
             548.                                           [29]  YANG C S,ZHANG L L,LIN Y Z,et al. Sodium val-
        [15]  王鑫,徐冲锋,张敏,等.阿立哌唑与氟哌啶醇治疗儿童抽                         proate for the treatment of Tourette’s syndrome in chil-
             动障碍疗效的 Meta 分析[J].中国社区医师,2018,34                    dren:a systematic review and meta-analysis[J]. Psychiatry
             (34):72-73.                                         Res,2015,226(2/3):411-417.
        [16]  方琼,陈琅,陈巧彬,等.阿立哌唑治疗儿童抽动障碍有效                    [30]  HUTCHISON S L,GHUMAN J K,GHUMAN H S,et al.
             性和安全性的Meta分析[J].中国当代儿科杂志,2015,17                    Efficacy of atomoxetine in the treatment of attention-defi-
             (7):715-720.                                        cit hyperactivity disorder in patients with common comor-
        [17]  YANG C S,HUANG H,ZHANG L L,et al. Aripiprazole     bidities in children,adolescents and adults:a review[J].
             for the treatment of tic disorders in children:a systematic  Ther Adv Psychopharmacol,2016,6(5):317-334.
             review and meta-analysis[J]. BMC Psychiatry,2015,15  [31]  LIU Z S,CUI Y H,SUN D,et al. Current status,diagnosis,
             (1):179-193.                                        and treatment recommendation for tic disorders in China
        [18]  GHANIZADEH A. Systemic review of aripiprazole for  [J]. Front Psychiatry,2020,11:774-790.
             the treatment of children and adolescents with tic disor-  [32]  YANG C,HAO Z L,ZHU C R,et al. Interventions for tic
             ders[J]. Neurosciences,2012,17(3):200-204.          disorders:an overview of systematic reviews and meta
        [19]  COX J H,SERI S,CAVANNA A E. Safety and efficacy of  analyses[J]. Neurosci Biobehav Rev,2016,63:239-255.
             aripiprazole for the treatment of pediatric Tourette syn-    (收稿日期:2021-05-09  修回日期:2021-09-16)
             drome and other chronic tic disorders[J]. Pediatric Health                          (编辑:舒安琴)




        ·2654 ·  China Pharmacy 2021 Vol. 32 No. 21                                 中国药房    2021年第32卷第21期
   99   100   101   102   103   104   105   106   107   108   109